Royal Bank of Canada’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.84M | Sell |
155,206
-6,452
| -4% | -$154K | ﹤0.01% | 2611 |
|
|
2025
Q4 | $3.77M | Sell |
161,658
-17,939
| -10% | -$400K | ﹤0.01% | 2650 |
|
|
2025
Q3 | $3.54M | Sell |
179,597
-33,625
| -16% | -$692K | ﹤0.01% | 2938 |
|
|
2025
Q2 | $4.63M | Sell |
213,222
-247
| -0.1% | -$5.83K | ﹤0.01% | 2631 |
|
|
2025
Q1 | $5.18M | Buy |
213,469
+60,040
| +39% | +$1.35M | ﹤0.01% | 2234 |
|
|
2024
Q4 | $3.2M | Sell |
153,429
-5,583
| -4% | -$120K | ﹤0.01% | 2665 |
|
|
2024
Q3 | $3.16M | Buy |
159,012
+85,654
| +117% | +$1.59M | ﹤0.01% | 2646 |
|
|
2024
Q2 | $1.14M | Buy |
73,358
+7,478
| +11% | +$116K | ﹤0.01% | 3334 |
|
|
2024
Q1 | $1.05M | Sell |
65,880
-23,860
| -27% | -$360K | ﹤0.01% | 3426 |
|
|
2023
Q4 | $1.51M | Buy |
89,740
+12,574
| +16% | +$172K | ﹤0.01% | 3306 |
|
|
2023
Q3 | $902K | Sell |
77,166
-11,968
| -13% | -$160K | ﹤0.01% | 3526 |
|
|
2023
Q2 | $1.2M | Buy |
89,134
+6,724
| +8% | +$96.8K | ﹤0.01% | 3221 |
|
|
2023
Q1 | $1.37M | Sell |
82,410
-5,930
| -7% | -$97.8K | ﹤0.01% | 3106 |
|
|
2022
Q4 | $1.64M | Buy |
88,340
+39,864
| +82% | +$614K | ﹤0.01% | 3076 |
|
|
2022
Q3 | $622K | Buy |
48,476
+6,155
| +15% | +$72.9K | ﹤0.01% | 3831 |
|
|
2022
Q2 | $297K | Sell |
42,321
-5,332
| -11% | -$39.1K | ﹤0.01% | 4479 |
|
|
2022
Q1 | $394K | Sell |
47,653
-12,786
| -21% | -$90.4K | ﹤0.01% | 4467 |
|
|
2021
Q4 | $410K | Buy |
60,439
+9,834
| +19% | +$64.7K | ﹤0.01% | 4654 |
|
|
2021
Q3 | $269K | Sell |
50,605
-98,132
| -66% | -$537K | ﹤0.01% | 4900 |
|
|
2021
Q2 | $855K | Buy |
148,737
+105,246
| +242% | +$543K | ﹤0.01% | 3798 |
|
|
2021
Q1 | $200K | Buy |
43,491
+1,138
| +3% | +$4.52K | ﹤0.01% | 4956 |
|
|
2020
Q4 | $142K | Sell |
42,353
-40,147
| -49% | -$135K | ﹤0.01% | 5111 |
|
|
2020
Q3 | $245K | Sell |
82,500
-667
| -0.8% | -$2.61K | ﹤0.01% | 4401 |
|
|
2020
Q2 | $384K | Sell |
83,167
-536
| -0.6% | -$2.41K | ﹤0.01% | 3982 |
|
|
2020
Q1 | $322K | Buy |
83,703
+1,203
| +1% | +$4.94K | ﹤0.01% | 3980 |
|
|
2019
Q4 | $309K | Sell |
82,500
-436
| -0.5% | -$2.04K | ﹤0.01% | 4315 |
|
|
2019
Q3 | $440K | Sell |
82,936
-7,440
| -8% | -$39.6K | ﹤0.01% | 3921 |
|
|
2019
Q2 | $347K | Sell |
90,376
-74,624
| -45% | -$322K | ﹤0.01% | 4105 |
|
|
2019
Q1 | $842K | Sell |
165,000
-6
| -0% | -$18 | ﹤0.01% | 3323 |
|
|
2018
Q4 | $317K | Sell |
165,006
-2,176
| -1% | -$6.23K | ﹤0.01% | 4046 |
|
|
2018
Q3 | $632K | Buy |
167,182
+1,956
| +1% | +$6.13K | ﹤0.01% | 3733 |
|
|
2018
Q2 | $516K | Buy |
165,226
+136
| +0.1% | +$413 | ﹤0.01% | 3766 |
|
|
2018
Q1 | $394K | Sell |
165,090
-440
| -0.3% | -$1.46K | ﹤0.01% | 3865 |
|
|
2017
Q4 | $647K | Sell |
165,530
-5,957
| -3% | -$19.7K | ﹤0.01% | 3596 |
|
|
2017
Q3 | $432K | Buy |
171,487
+6,446
| +4% | +$17.7K | ﹤0.01% | 3917 |
|
|
2017
Q2 | $455K | Buy |
165,041
+41
| +0% | +$86 | ﹤0.01% | 3723 |
|
|
2017
Q1 | $322K | Sell |
165,000
-1,013
| -0.6% | -$1.29K | ﹤0.01% | 3990 |
|
|
2016
Q4 | $174K | Sell |
166,013
-70,048
| -30% | -$80K | ﹤0.01% | 4570 |
|
|
2016
Q3 | $257K | Buy |
236,061
+71,031
| +43% | +$63.9K | ﹤0.01% | 4248 |
|
|
2016
Q2 | $117K | Buy |
+165,030
| New | +$133K | ﹤0.01% | 4713 |
|
|
2015
Q4 | – | Sell |
-3,764
| Closed | -$11K | – | 6657 |
|
|
2015
Q3 | $11K | Sell |
3,764
-823
| -18% | -$3.55K | ﹤0.01% | 5841 |
|
|
2015
Q2 | $19K | Buy |
4,587
+2,987
| +187% | +$11.9K | ﹤0.01% | 5722 |
|
|
2015
Q1 | $7K | Sell |
1,600
-400
| -20% | -$1.44K | ﹤0.01% | 5654 |
|
|
2014
Q4 | $6K | Hold |
2,000
| – | – | ﹤0.01% | 5746 |
|
|
2014
Q3 | $7K | Hold |
2,000
| – | – | ﹤0.01% | 5566 |
|
|
2014
Q2 | $5K | Sell |
2,000
-56
| -3% | -$120 | ﹤0.01% | 5556 |
|
|
2014
Q1 | $5K | Buy |
2,056
+56
| +3% | +$117 | ﹤0.01% | 5564 |
|
|
2013
Q4 | $4K | Hold |
2,000
| – | – | ﹤0.01% | 5639 |
|
|
2013
Q3 | $6K | Hold |
2,000
| – | – | ﹤0.01% | 5572 |
|
|
2013
Q2 | $2K | Buy |
+2,000
| New | +$1.6K | ﹤0.01% | 5608 |
|
Other funds holding CPRX
VCM
DM
VPM
Royal Bank of Canada's CPRX Position: Q1 2026 in Review
Royal Bank of Canada reduced its Catalyst Pharmaceutical (CPRX) stake by 4% in Q1 2026, selling an estimated $154K and leaving 155,206 shares worth $3.84M. The position accounts for ﹤0.01% of the portfolio, ranked #2611.
Royal Bank of Canada first reported a position in CPRX in Q2 2013 and has held it in 50 quarters since. The position peaked at $5.18M in Q1 2025. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.
- Royal Bank of Canada held 155,206 shares of Catalyst Pharmaceutical worth $3.84M as of Q1 2026.
- Royal Bank of Canada sold 6,452 Catalyst Pharmaceutical shares in Q1 2026, an estimated $154K.
- Catalyst Pharmaceutical made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #2611 holding.
- Royal Bank of Canada first reported a position in Catalyst Pharmaceutical in Q2 2013 and has held it in 50 quarters since.
- Royal Bank of Canada's Catalyst Pharmaceutical position peaked at $5.18M in Q1 2025.
- 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.